| Unique ID issued by UMIN | UMIN000059173 |
|---|---|
| Receipt number | R000067682 |
| Scientific Title | Repeated Application Study of RETISOME IDB Facial Serum |
| Date of disclosure of the study information | 2025/09/30 |
| Last modified on | 2025/09/24 12:41:39 |
Repeated Application Study of RETISOME IDB Facial Serum
Repeated Application Study of RETISOME IDB Facial Serum
Repeated Application Study of RETISOME IDB Facial Serum
Repeated Application Study of RETISOME IDB Facial Serum
| Japan |
healthy adults
| Adult |
Others
NO
To evaluate improvements in skin and stratum corneum condition following facial application of a serum containing Retisome IDB.
Efficacy
VISIA
・Stratum corneum analysis:Stratum corneum area ,Multiple peeling degree, Stratum corneum roundness, Amount of melanin, Carbonyl protein (CP)
・Measurement equipment:Moisture content measurement (Corneometer), TEWL measurement (Tewameter), Skin viscoelasticity measurement (Cutometer)
・Usability questionnaire
Interventional
Single arm
Non-randomized
Open -no one is blinded
Self control
1
Prevention
| Other |
Apply the serum twice a day to all faces for 8 weeks.
| 18 | years-old | <= |
| 60 | years-old | > |
Male and Female
・Healthy males and females in the age more than 20 and less than 60 years.
・Particpants who are concerned about sagging and wrinkles of skin.
・Particpants who are concerned about spots and dullness of skin.
・Particpants who are concerned about dry skin.
・During the examination period, Particpants who can avoid sun exposure and implement UV protection measures.
・Participants with alcoholic.
・During the examination period, Participants who plan to begin new beauty treatment (such as esthetic treatment and aesthetic medicine.) and have newly started it within the past two months.
・During the examination period, Participants who plan to change their usual lifestyle habits. (such as starting or stopping a diet and changing sleep habits.)
・Participants with skin conditions. (such as face skin inflammation.)
・Participants who participated in other studies one month prior to the date of consent or scheduled to participate in studies.
・Participants who are pregnant, breastfeeding, or planning pregnancy during the study period.(including immediately after childbirth.)
・Participants with cosmetics allergies or a history of them.
・Participants with hormone replacement therapy.
・Participants with taking treatment a disease and medicine.
10
| 1st name | Daisuke |
| Middle name | |
| Last name | Maeda |
JC Dermatology Laboratory Co., LTD.
research and development division
160-0022
Shinjuku 1-chome Bldg. 8F, 1-10-4 Shinjuku, Shinjuku-ku, Tokyo 160-0022, Japan
03-3359-5330
d-maeda@jc-dermalabo.jp
| 1st name | Daisuke |
| Middle name | |
| Last name | Maeda |
JC Dermatology Laboratory Co., LTD.
research and development division
160-0022
Shinjuku 1-chome Bldg. 8F, 1-10-4 Shinjuku, Shinjuku-ku, Tokyo 160-0022, Japan
03-3359-5330
d-maeda@jc-dermalabo.jp
JC Dermatology Laboratory Co., LTD.
JC Dermatology Laboratory Co., LTD.
Profit organization
Tokyo Shinjuku Clinic Ethical Review Board
SIL Shinjuku 5F, 2-46-3, Kabukicho, Shinjuku-ku, Tokyo,Japan
03-6709-6071
irb@ml.taifukukai.jp
NO
| 2025 | Year | 09 | Month | 30 | Day |
Unpublished
Preinitiation
| 2025 | Year | 09 | Month | 05 | Day |
| 2025 | Year | 09 | Month | 12 | Day |
| 2025 | Year | 10 | Month | 14 | Day |
| 2025 | Year | 12 | Month | 31 | Day |
| 2025 | Year | 09 | Month | 24 | Day |
| 2025 | Year | 09 | Month | 24 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067682